-
Join me in encouraging the ACS to join the Initiative for Open Citations
My research is into abstract representation of chemical information, important for other research to be performed. Indeed, my work is generally reused, but knowing which research fields my work is used in, or which societal problems it is helping solve, is not easily retrieved or determined. Efforts like WikiCite and Scholia do allow me to navigate the citation network, so that I can determine which research fields my output influences and which diseases are studied with methods I proposed. Here’s a network of topics of articles citing my work: -
New paper: "Integration among databases and data sets to support productive nanotechnology: Challenges and recommendations"
The U.S.A and European nanosafety communities have a longstanding history of collaboration. On both sides there are working groups, NanoWG and WG-F (previously called WG4) of the NanoSafety Cluster. I have been chair of WG4 for about three years and still active in the group, though in the past half year, without dedicated funding, less active. That is already changing again with the imminent start of the NanoCommons project. -
Migrating pKa data from DrugMet to Wikidata
In 2010 Samuel Lampa and I started a pet project: collecting pKa data: he was working on RDF extension of MediaWiki and I like consuming RDF data. We started DrugMet. When you read this post, this MediaWiki installation may already be down, which is why I am migrating the data to Wikidata. Why? Because data curation takes effort, I like to play with Wikidata (see this H2020 proposal by Daniel Mietchen et al.), I like Open Data, and it still much needed. -
Adding disclosures to Wikidata with Bioclipse
Last week the huge, bi-annual ACS meeting took place (#ACSSanDiego), during which commonly new drug (leads) are disclosed. This time too, like this one tweeted by Bethany Halford: